Phaarmasia Ltd PE Ratio

Phaarmasia PE Ratio

Image

Phaarmasia Ltd

NSE: PHAARMASIA

PE

27.1

Last updated on: Sep 07, 2026

Key Highlights

  • The P/E Ratio of Phaarmasia Ltd is 27.1 as of 07 Sep 26 The P/E Ratio of Phaarmasia Ltd changed from 54 on March 2021 to 0 on March 2025 . This represents a CAGR of -100.00% over 5 years .

Historical P/E Ratio of Phaarmasia Ltd

No data available

Company Fundamentals for Phaarmasia Ltd

Image

Phaarmasia Ltd

NSE: PHAARMASIA

Share Price

₹ -

Last updated on: Jan 01, 2026

Market Price of Phaarmasia Ltd

1M

1Y

3Y

5Y

Monitoring Phaarmasia Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
07 Sep 202686.7
04 Sep 202682.6
03 Sep 202685.8
02 Sep 202690.3
01 Sep 202695.05
31 Aug 2026100.02
28 Aug 202695.59
27 Aug 202686.9
26 Aug 202682.4
25 Aug 202676

BlinkX Score for Phaarmasia Ltd

Asset Value vs Market Value of Phaarmasia Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Key Valuation Metric of Phaarmasia Ltd

X

Historical Market Cap of Phaarmasia Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Phaarmasia Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Phaarmasia Ltd

No data available

* All values are in %

About Phaarmasia Ltd

  • Incorporated in 1981, Phaarmasia Limited is a manufacturing unit dedicated in manufacturing facility of Hormonal (Oral contraceptive tablets) and Combipack with Iron Tablet.
  • M/s Phaarmasia Limited Unit-II was established in 1993-94. The plant is situated in a hygienic environment; free from dust, smoke, chemical & biological emission.
  • Phaarmasia Ltd. Is an independent State-of-the-art-manufacturing unit having manufacturing facility of international standards with manufacturing capacity of more than 30 million units per annum. During the year 2000, the company became a Sick Industrial Company under SICA and therefore the same was referred to the BIFR. During past a few decades, Phaarmasia mastered and manufactured wide range of Pharmaceutical Formulations at a WHO-GMP certified and ISO 9001-certified manufacturing facility.

Phaarmasia Ltd News Hub

Phaarmasia reports standalone net profit of Rs 0.28 crore in the June 2024 quarter

Net profit of Phaarmasia reported to Rs 0.28 crore in the quarter ended June 2024 as against net los

Read more

12 Aug 24

Phaarmasia to discuss results

Phaarmasia will hold a meeting of the Board of Directors of the Company on 12 August 2024. Powered b

Read more

10 Aug 24

Phaarmasia to hold board meeting

Phaarmasia will hold a meeting of the Board of Directors of the Company on 5 November 2024 Powered b

Read more

02 Nov 24

Phaarmasia reports standalone net loss of Rs 0.64 crore in the September 2024 quarter

Net Loss of Phaarmasia reported to Rs 0.64 crore in the quarter ended September 2024 as against net

Read more

06 Nov 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions